Our Scientists and Researchers
Terry Michael Fredeking
President – Antibody Systems, Inc.
President – Global Disease Research
In 1977 Terry Fredeking founded Antibody Systems, Inc (ASI) a leading supplier of raw materials for diagnostic and therapeutic products for national and international pharmaceutical companies. ASI has participated in clinical research resulting in FDA approval for products such as Hepatitis B Vaccine, Cholera Vaccine, and Typhoid Vaccine.
Terry has been directly involved in researching treatments for diseases through Cooperative Research Agreements (CRADA) and collaborations with various government, private, and university laboratories in the United States. Read more...
Tracy H. Goen, M.D.
Dr. Tracy Goen began his colorful career as a Harvard University graduate student majoring in Archaeology.. His focus was in the area of Human origins/evolutionary theory, and worked with Dr. Richard Leakey in Kenya excavating early human fossil remains. His quest for knowledge took him to Medical School at Texas A&M College of Medicine where he graduated with a masters in veterinarian medicine and a Doctorate in human medicine. Read more...
His love for Africa and humanitarian work established his position as a missionary Medical Director of Egbe Hospital in Egbe, Nigeria for the next seven years. His work with the Fulani (cattlemen) and the Yoruba (farmers) tribes resulted in his being honored with the position "chief" in the Yoruba and a working "King" in the Fulani tribe.
Tracy is currently practicing medicine in Johnson City and Bristol Tennessee. He is the Medical Director and Scientific Board member of Global Disease Research and returns to Africa twice per year.
Michael Foster, MPH
Mike is currently teaching Biology at the University of North Texas, Denton while finishing his Ph.D. in biology. He is a graduate of the Health Science Center, Fort Worth and plans to attend medical school after his PhD.
Mike has worked on the GDR dengue project done at the University of Mexico Medical school in Merida, Yucatan. Read more...
His duties consisted of data collection and surveillance from the clinical trial of dengue patients hospitalized with Dengue Hemorrhagic Fever.
Mike has firsthand experience with the patient outcome of this deadly condition. He is a co-author on the publication that showed a 50% decrease in death rates as the result of GDR's treatment protocol.
Mike, Tracy, and Aileen are now part of a ongoing study in west Africa. The study is focusing on co-infections with Dengue, Malaria, and HIV in the same patient with the hope of treatment possibilities from what was learned in the Mexico study's. Mike has made seven trips to Mexico and four trips to Africa regarding the GDR Dengue project. Mike isn't sure what time zone he lives in.
Michael J. Ricciardi, PHD
Alfonso J. Rodríguez-Morales, MD, PHD
Dr. Alfonso J. Rodriguez-Morales is the Secretary of the Colombian Infectious Diseases Association (ACIN) (2015-2017), President of the Committee of Travel Medicine of the Pan-American Infectious Diseases (API) (2015-2017), Co-Chair of the Working Group on Zoonoses of the International Society for Chemotherapy (ISC) and member of the directive board of the Latin American Society for Travel Medicine (SLAMVI). He earned his MD degree at the Universidad Central de Venezuela (UCV) and later a MSc in Protozoology at the Universidad de Los Andes from Venezuela. Read more...
He holds a Diploma in Tropical Medicine & Hygiene (DTM&H) from Universidad Peruana Cayetano Heredia/University of Birminghan at Alabama. He was trained in Social Epidemiology with the European Educational Program in Epidemiologgy in Italy, in Surveillance of Communicable Diseases with the WHO-Swiss Tropical Medicine and Public Health Institute (STI) at Switzerland and in Tropical Medicine with the STI in Tanzania, Africa.
He is also Fellow of the Faculty of Travel Medicine of the Royal College of Surgeons and Physicians of Glasgow (FFTM RCPSG) and also Fellow of the Royal Society for Tropical Medicine & Hygiene (RSTMH). He is currently PhD candidate in Parasitology at the UCV. Dr. Rodriguez-Morales is currently member of the Study Groups for Clinical Parasitology (ESGCP) and for Infections in Travelers and Migrants (ESGITM) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). His research interests and international publications include epidemiology of severe P. vivax malaria, impact of climate change on infectious diseases (particularly on leishmaniasis and dengue), Chagas disease and more recently Chikungunya (CHIKV) and Zika (ZIKV). He chairs the Colombian Collaborative Network of Research on Zika (RECOLZIKA). As leader of research teams in Colombia, have published over 50 papers on acute and chronic consequences of CHIKV and ZIKV, including the first studies in Latin America regard associated chronic inflamatory rheumatism post-CHIKV and its disability as well about its congenital infection, as well the first of triple coinfection with DENV, CHIKV and ZIKV, and the first reports of ZIKV associated mortality. With over 250 papers in international journals his H-index is 16. He is currently lecturer and senior researcher (recognized twicely by the National Agency of Sciences, Colciencias, 2015-2019) of the Universidad Tecnologica de Pereira in Colombia.